Evidence map›Paper›PMID 39664250›Full record

ArticleRSC advances2024

Controllable rheological properties of UV-responsive calix[4]arene gel for drug encapsulation and release.

Ji Ha Lee, Wataru Kanda, Tomoyuki Tachibana, Minhye Kim, Sung Ho Jung, Riku Kawasaki, Akihiro Yabuki

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ji Ha LeeInstitute for Fiber Engineering (IFES), Faculty of Textile Science and Technology, Shinshu University 3-15-1 Tokita Ueda 386-8567 Japan leejiha@shinshu-u.ac.jp +81 26 821 5571.ORCID https://orcid.org/0000-0002-4456-0128
Wataru KandaChemical Engineering Program, Graduate School of Advanced Science and Engineering, Hiroshima University 1-4-1 Kagamiyama Higashi-Hiroshima 739-8527 Japan.
Tomoyuki TachibanaChemical Engineering Program, Graduate School of Advanced Science and Engineering, Hiroshima University 1-4-1 Kagamiyama Higashi-Hiroshima 739-8527 Japan.
Minhye KimDepartment of Chemistry, Research Institute of Advanced Chemistry, Gyeongsang National University Jinju 52828 Republic of Korea.
Sung Ho JungDepartment of Chemistry, Research Institute of Advanced Chemistry, Gyeongsang National University Jinju 52828 Republic of Korea.ORCID https://orcid.org/0000-0002-5585-1086
Riku KawasakiApplied Chemistry Program, Graduate School of Advanced Science and Engineering, Hiroshima University Higashi-Hiroshima 739-8527 Japan.ORCID https://orcid.org/0000-0003-1621-8189
Akihiro YabukiChemical Engineering Program, Graduate School of Advanced Science and Engineering, Hiroshima University 1-4-1 Kagamiyama Higashi-Hiroshima 739-8527 Japan.ORCID https://orcid.org/0000-0002-5799-3301

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the potential of calix[4]arene-based supramolecular gels for use in drug delivery systems, focusing on both their rheological properties and controlled drug release behavior. We explore how key factors, including temperature, solvent exchange, and UV exposure, influence the gel's mechanical strength and its ability to encapsulate and release drugs. Specifically, our work examines how these external stimuli affect the stability of the gel matrix and modulate the release rate of the encapsulated drug. By systematically evaluating the effects of each factor, we aim to identify conditions that optimize drug release kinetics. The findings offer valuable insights into the development of a tunable, responsive platform for efficient drug delivery, highlighting the potential of calix[4]arene gels as promising candidates for advanced therapeutic applications.

Identifiers

PMID39664250
PMCPMC11632593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.